
Busulfan
CAS No. 55-98-1
Busulfan( Busulphan | Mielosan | Milecitan | Myeloleukon | Mylecytan | Myleran | NCI C01592 | NSC 750 )
Catalog No. M15037 CAS No. 55-98-1
Busulfan is a bifunctional alkylating agent.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | 41 | In Stock |
![]() ![]() |
1G | 56 | In Stock |
![]() ![]() |
Biological Information
-
Product NameBusulfan
-
NoteResearch use only, not for human use.
-
Brief DescriptionBusulfan is a bifunctional alkylating agent.
-
DescriptionBusulfan is a bifunctional alkylating agent.
-
In VitroWestern Blot Analysis Cell Line:WI38 cells Concentration:120 μM Incubation Time:24 hours Result:Incited a moderate p53 activation, but strong Erk, p38, and JNK phosphorylation, in a time-dependent manner. Elicited an immediate up-regulation of p21 expression, which subsided by day 11.
-
In VivoAnimal Model:ICR male mice ranging in age from 8 to 12 weeks (30-40 g) Dosage:40 mg/kg (in sesame oil) Administration:IP; single dose Result:Increased apoptosis and decreased the testis weight in mice. Exhibited higher level of pRB expression, inhibited Rb phosphorylation and PCNA expression compared to the control.
-
SynonymsBusulphan | Mielosan | Milecitan | Myeloleukon | Mylecytan | Myleran | NCI C01592 | NSC 750
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylation
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number55-98-1
-
Formula Weight246.3
-
Molecular FormulaC6H14O6S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 49 mg/mL (198.94 mM)
-
SMILESCS(=O)(OCCCCOS(C)(=O)=O)=O
-
Chemical Namebutane-1,4-diyl dimethanesulfonate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Meng A, et al. Y Res, 2003, 63(17), 5414-5419.
molnova catalog



related products
-
Lomustine
Lomustine is an Alkylating Drug. The mechanism of action of lomustine is as an Alkylating Activity.
-
KCC-07
KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
-
OBI-3424
OBI-3424 (AST-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent.